Vimarsana
Biggest News Aggregation in the World

Page 3 - Data Coordinating Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Data Coordinating Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Data Coordinating Center Today - Breaking & Trending Today

Ohio State receives $12M to study effectiveness of therapies for gestational diabetes - Vimarsana News

Ohio State receives $12M to study effectiveness of therapies for gestational diabetes

Gestational diabetes is on the rise among pregnant people, and now a research team at The Ohio State University Wexner Medical Center has received a $12 million funding award from the Patient-Centered Outcomes Research Institute (PCORI) to define the best treatment when medication becomes necessary.

Medication for Opioid Use Disorder During Pregnancy — Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014–2021 - Vimarsana News

Medication for Opioid Use Disorder During Pregnancy — Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014–2021

This report describes medication for opioid use disorder during pregnancy.

Source: cdc.gov
Daily statin reduces the risk of cardiovascular disease in people living with HIV, large NIH study finds - Vimarsana News

Daily statin reduces the risk of cardiovascular disease in people living with HIV, large NIH study finds

A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population. A planned interim analysis of data from theA National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to tes...

Daily statin medication could improve cardiovascular outcomes in people with HIV - Vimarsana News

Daily statin medication could improve cardiovascular outcomes in people with HIV

A National Institutes of Health clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population.

Janice L. Pringle - Vimarsana News

Janice L. Pringle

Janice L. Pringle’s profile on The Conversation